Form 4: VolitionRx CEO Butera Acquires Shares, Disposes of Some for Tax Obligations
SEC Form 4 Filing
CEO Salvatore Thomas Butera of VolitionRx Ltd. reports acquiring and disposing of common stock related to tax obligations from restricted stock units.
Summary
- On May 1, 2025, Salvatore Thomas Butera, CEO of Volition Veterinary and an officer of VolitionRx Ltd., engaged in transactions involving the company's common stock.
- Butera disposed of 10,205 shares to cover tax withholding obligations related to the settlement of 31,256 restricted stock units, with the shares valued at $0.4875 each.
- No shares were sold by Butera or VolitionRx in this transaction.
- Following the transaction, Butera directly owns 302,685 shares of common stock.
- Butera also jointly owns 99,350 shares of common stock with his spouse.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.
Key Dates
| Date | Description |
|---|---|
| 05/01/2025 | Date of transaction involving common stock. |
| 05/05/2025 | Date of signature for the Form 4 filing. |
Keywords
VolitionRx, VNRX, Salvatore Thomas Butera, CEO, Form 4, Beneficial Ownership, Restricted Stock Units, Tax Withholding, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.